UNSPSC 85815424: Introduction of low-dose interleukin-2 into central artery, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into central artery, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E06003

UNSPSC 85815424, Introduction of low-dose interleukin-2 into central artery, open approach, is a Commodity code that nominally describes a highly specialized invasive immunotherapy procedure. State and local procurement activity under this code shows no recent relevant opportunities; the opportunities tagged to it span virtual urgent care services, occupational health, cancer screening, EMS staffing, opioid treatment, youth crisis services, and employee wellness platforms—none of which involve interleukin-2 infusion or interventional cardiology. The source reflects a classification mismatch between the UNSPSC taxonomy label and the actual work state and local governments are procuring.

The code shows minimal decision relevance for vendors pursuing state and local work. Issuers tagging procurements to this code span California health plans, Georgia counties, Nevada health authorities, Colorado departments, and Texas facilities, but none are sourcing the procedure the code nominally describes. Watch this code for corrected tagging or reclassification rather than pursue it; current opportunities reflect broad healthcare service contracting across numerous service lines that are better tracked through codes for telehealth, occupational health, opioid treatment services, and behavioral health instead.